Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Harvard Business School
McKinsey
Baxter
Moodys

Last Updated: September 30, 2022

Details for Patent: 9,180,091


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 9,180,091
Title:Soluble estradiol capsule for vaginal insertion
Abstract: According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.
Inventor(s): Bernick; Brian A. (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL), Persicaner; Peter H. R. (Boca Raton, FL), Irani; Neda (Palm Beach Gardens, FL), Cacace; Janice Louise (Miami, FL), Thorsteinsson; Thorsteinn (Boca Raton, FL), Sancilio; Frederick D. (Palm Beach Gardens, FL)
Assignee: TherapeuticsMD, Inc. (Boca Raton, FL)
Application Number:14/136,048
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,180,091
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 9,180,091

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Therapeuticsmd Inc IMVEXXY estradiol INSERT;VAGINAL 208564-001 May 29, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY See Plans and Pricing
Therapeuticsmd Inc IMVEXXY estradiol INSERT;VAGINAL 208564-001 May 29, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y TREATMENT OF DYSPAREUNIA See Plans and Pricing
Therapeuticsmd Inc IMVEXXY estradiol INSERT;VAGINAL 208564-002 May 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY See Plans and Pricing
Therapeuticsmd Inc IMVEXXY estradiol INSERT;VAGINAL 208564-002 May 29, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y TREATMENT OF DYSPAREUNIA See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,180,091

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 095619 See Plans and Pricing
Argentina 098160 See Plans and Pricing
Argentina 099872 See Plans and Pricing
Argentina 107022 See Plans and Pricing
Australia 2012340589 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Moodys
Express Scripts
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.